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Research
Underground water in many regions of 
the world is contaminated with arsenic (As), 
and the resulting toxicity has created a major 
environ  mental and public health problem in the 
affected regions. Chronic As exposure can cause 
many diseases, including neuro  develop  mental 
disorders and brain disease. Arsenic—along with 
As compounds—is one of the five industrial 
chemicals proven to cause neuro  developmental 
disorders among thousands of known chemicals 
(Grandjean and Landrigan 2006). In rats, As 
exposure during the rapid brain-growth period 
causes faulty migration, delayed maturation, 
and alteration in nuclear area measure  ments of 
Purkinje cells in the cerebellum and impaired 
brain structural organization and the shape of 
fiber tracts and axons in the striatum (Dhar 
et al. 2007; Rŕos et al. 2009). Although accu-
mulating evidence for neuro  developmental 
neuro  toxicity of As is established, the causative 
mechanism remains unclear. The toxic effects of 
As on children have generally been overlooked, 
and regulatory action does not emphasize the 
need to protect the developing brain against this 
neuro  toxic substance (Mukherjee et al. 2006).
Adenosine monophosphate-activated 
kinase (AMPK) is an important integrator 
of signals that control cellular energy balance 
through the regulation of multiple bio  chemical 
pathways (Hardie et al. 1999). Recent studies 
have suggested that AMPK also regulates cell 
structure and polarity, cell division, and nor-
mal growth and development (Dasgupta and 
Milbrandt 2009; Lee et al. 2007). AMPK helps 
maintain genomic integrity in neuron precur-
sors and the structure and function of mature 
neurons in Drosophila (Lee et al. 2007). Loss 
of AMPK activity causes neuro  degeneration in 
Drosophila (Spasić et al. 2008) and structural 
and functional brain abnormalities in AMPK-
mutant mice (Dasgupta and Milbrandt 2009). 
The activation of AMPK contributes to the 
stimu  lating effect of resveratrol on neurite out-
growth in neurons (Dasgupta and Milbrandt 
2007). These studies suggest that AMPK may 
have additional roles beyond the established 
metabolic functions, both in neuronal develop-
ment and in neuro  degenerational diseases.
AMPK exists in cells as a hetero  trimeric 
complex containing a catalytic α sub-
unit, a scaffolding β subunit, and an AMP-
binding γ subunit. The activation of AMPK 
requires phosphorylation of Thr172 in the 
activation loop of the catalytic α subunit 
[AMPKα(Thr172)] (Shaw et al. 2004). Recent 
studies have identified LKB1 (serine/threonine 
kinase 11) and Ca2+/calmodulin-dependent 
protein kinase kinase-β (CaMKKβ) as two 
kinases that phosphorylate Thr172 (Carling 
et al. 2008; Woods et al. 2003). LKB1 signaling 
is regulated through two main mecha  nisms: 
phosphorylation and sub  cellular localization. 
In resting cells, LKB1 is reported to be pre-
dominantly located in the nucleus (Tiainen 
et al. 1999); however, the cyto  plasmic localiza-
tion of LKB1 is critical for its normal function 
(Boudeau et al. 2003). LKB1 forms a hetero-
trimeric complex with the regulatory proteins 
ste20-related adaptor (STRAD) and mouse 
protein 25 (MO25), which causes a relocaliza-
tion of LKB1 to the cytosol and enhances 
LKB1 activity (Shaw et al. 2004; Xie et al. 
2008). LKB1 can be phosphorylated on sev-
eral residues, and recent evidence suggests that 
phosphorylation of LKB1 at Ser428 increases 
export of LKB1 from the nucleus and influ-
ences the ability of LKB1 to bind and phospho-
rylate AMPK at Thr172 (Song et al. 2008; Xie 
et al. 2006, 2008). In addition, LKB1 itself has 
roles in regulating cellu  lar polarity and struc-
ture, such as promoting axon initiation during 
neuronal polarization in cultured hippocampal 
neurons (Shelly et al. 2007) and regulating neu-
ronal migration and neuronal differentiation in 
the developing neo  cortex (Asada et al. 2007).
Neurite outgrowth is an early process of 
neuronal differentiation, which can be regu  lated 
by a large number of signals, such as mitogen-
activated protein kinase and glycogen synthase 
kinase pathways (Chen et al. 2009; DeFuria 
and Shea 2007). Considering the potential 
role of AMPK in neuronal develop  ment, we 
hypothesized that impairment of AMPK acti-
vation was involved in the neuro  developmental 
toxicity induced by As. Using the Neuro-2a 
(N2a) neuronal cell model, we designed the 
present study to determine whether As induced 
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Ba c k g r o u n d: Arsenic (As) is an environmental pollutant that induces numerous pathological 
effects, including neurodevelopmental disorders. 
oBjectives a n d Me t h o d s : We evaluated the role of the LKB1–AMPK pathway in As-induced devel-
opmental neuro  toxicity using Neuro-2a (N2a) neuroblastoma cells as a model of developing neurons.
re s u l t s: The addition of low concentrations of As (≤ 5 µM) during differentiation caused an   
inhibi  tory effect on the neurite outgrowth in N2a cells in the absence of cell death. Activation of 
adeno  sine monophosphate–activated kinase (AMPK) induced by retinoic acid in differentiating cells 
was blocked by As. Pretreatment with the AMPK-specific activator 5-amino  imidazole-4-carboxamide 
riboside or over  expression of a constitutively active AMPK-α1 plasmid reversed As-induced inhibi-
tion of neurite outgrowth. The activation of LKB1 (serine/threonine kinase 11), a major AMPK 
kinase, was also suppressed by As by inhibiting both the phosphorylation and the trans  location of 
LKB1 from nucleus to cytoplasm. Antioxidants, such as N-acetyl cysteine and superoxide dismutase, 
but not catalase, protected against As-induced inactivation of the LKB1–AMPK pathway and 
reversed the inhibitory effect of As on neurite outgrowth. 
co n c l u s i o n s: Reduced neurite outgrowth induced by As results from deficient activation of AMPK 
as a consequence of a lack of activation of LKB1. Oxidative stress induced by As, especially excessive 
superoxide, plays a critical role in blocking the LKB1–AMPK pathway. Our studies provide insight 
into the mechanisms underlying As-induced developmental neurotoxicity, which is important for 
designing a new strategy for protecting children against this neurotoxic substance.
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neuro  develop  mental toxicity and to investigate 
the role of AMPK in this process. N2a, a mouse 
neuro  blastoma cell line, is widely used to study 
the mechanisms of neuronal differentiation. In 
response to serum starvation or treatment with 
retinoic acid (RA) or dibutyryl cyclic AMP, 
N2a cells undergo neuronal differentiation 
characterized by cell cycle arrest, neurite out-
growth, and up-regulation of neuro  filament 
(NF) proteins (Dasgupta and Milbrandt 2007). 
In the present study, we determined that As 
inhibited neurite outgrowth in N2a cells; this 
inhibitory effect was induced by suppressing the 
LKB1–AMPK pathway, which appears to play 
an important role in neuronal differentia  tion. 
Antioxidants, such as N-acetyl cysteine (NAC) 
and superoxide dismutase (SOD), antagonized 
the inhibitory effect of As, indicating that reac-
tive oxygen species (ROS) play an important 
role in neuronal differentiation and mediating 
the action of As.
Materials and Methods
Chemicals. Nucleofector Kit V was pur-
chased from Amaxa (Cologne, Germany), 
protein G-Sepharose beads were purchased 
from Amersham Biosciences (Pittsburgh, PA, 
USA), and other chemicals were obtained 
from Sigma Chemical Co. (St. Louis, MO, 
USA) unless otherwise stated. We pur-
chased STRAD and lamin A/C anti  bodies 
from Santa Cruz Biotechnology Inc. (Santa 
Cruz, CA, USA) and other antibodies from 
Cell Signaling Technology Inc. (Beverly, 
MA, USA). Plasmids encoding a c-myc–
tagged constitutively active form of AMPKα 
(CA-AMPK) or a dominant negative form of 
AMPKα (DN-AMPK) were generous gifts 
from J. Suttles (Louisville, KY, USA).
Figure 1. Arsenic inhibits neurite outgrowth in N2a cells. Cells were induced to differentiate for 48 hr in media containing RA or RA plus 0.5–5 µM As (A) or for 
0–48 hr in growth medium alone without treatment (control), RA, or RA plus 3 µM As (B). Images are typical fields of cells viewed with an inverted light microscope; 
bars = 100 µm. (C) Percentage of cells exhibiting neurites (left) and the average length of neurites (right) in 200 cells treated as in A (top) and as in B (bottom). Each 
data point is the mean ± SE of three independent experiments.
*p < 0.05 compared with RA treatment alone. 
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Cell cultures and N2a cell differentia-
tion. N2a cells were cultured in Dulbecco’s 
modified Eagle’s medium (DMEM) supple-
mented with 10% fetal bovine serum (FBS), 
2 mM l-glutamine, 100 U/mL penicillin, and 
100 µg/mL streptomycin at 37°C in 5% CO2 
in a humidified atmosphere. To induce dif-
ferentiation, growth medium was carefully 
removed and then replaced with an equal 
volume of DMEM supplemented with 2% 
FBS, 2 mM l-glutamine, 100 U/mL peni-
cillin, 100 µg/mL streptomycin, and 20 µM 
all-trans RA. Arsenic trioxide was dissolved in 
1 N sodium hydroxide and then diluted to 
1 mM with phosphate-buffered saline (PBS); 
this was used as stock solution.
Cytotoxicity assessment. Confirmation 
of cell viability was performed and quanti-
fied by the 3-(4,5-dimethyl-thiazol-2-yl)-2,5-
diphenyl  tetra  zolium bromide (MTT) assay as 
previously described (Wang et al. 2007).
Quantification of neurite outgrowth. To 
count the number of cells expressing neu-
rites and measure neurite length, we stained 
cells using crystal violet. Briefly, cultures dif-
ferentiated in the presence or absence of As 
in six-well plates were washed in PBS before 
fixation with ice-cold methanol at –20°C for 
15 min; cells were then stained with 0.5% 
crystal violet solution in methanol for 30 min 
at room temperature. Using an inverted light 
microscope at 320× magnification, we scored 
for the percentage of cells expressing neurites 
and determined average neurite length. Cells 
with neurites were defined as cellular exten-
sions greater than two cell body diameters 
in length (Keilbaugh et al. 1991). Neurite 
length was measured as the distance from the 
center of the cell soma to the tip of its longest 
neurite (Chen et al. 2009). Five random fields 
were examined from each well, giving a total 
cell count of at least 200 cells/well. Each data 
point represents the mean of three individual 
wells in one experiment, and each experiment 
was repeated three times.
Immunoblotting and immuno  precipitation. 
Fractionation of cytoplasm and nuclear protein 
was achieved as previously described (Wang 
et al. 2007). Briefly, N2a cells were lysed in an 
ice-cold lysis buffer [5 mM EDTA, 1% NP-40 
(nonyl phenoxyl  poly  ethoxyl  ethanol), 10 mg/
mL phenyl  methyl  sulfonyl fluoride, 10 µg/
mL leupeptin, and 100 mM sodium ortho-
vanadate in PBS] and centrifuged at 20,800 × g 
for 10 min. The supernatant was designated as 
the cytoplasmic fraction. The pellets were soni-
cated in a nuclear extraction buffer [20 mM 
Tris-HCl, pH 7.5, 1% sodium dodecyl sulfate, 
5 mM EDTA, 0.5% Triton X-100, 150 mM 
NaCl, 1 mM dithiothreitol, 10 µg/mL leu-
peptin, and 1 mM 4-(2-aminoethyl) benzene-
sulfonyl fluoride hydrochloride] and centrifuged 
at 20,800 × g for 10 min. The supernatant was 
collected and designated as the nuclear fraction.
The procedure for immunoblotting and 
immuno  precipitation has been previously 
described (Wang et al. 2007). Each experiment 
was repeated three times independently. The 
signal was analyzed by quantitative densi  tometry 
using ImageJ software (version 1.42; National 
Institutes of Health, Bethesda, MD, USA).
Immunofluorescence. Immunocyto  fluores-
cent staining of phosphorylated LKB1(Ser428) 
[p-LKB1(Ser428)] was performed as previ-
ously described (Wang et al. 2007). N2a cells 
cultured on coverslips were treated with RA 
in the absence or presence of As for 24 hr and 
then fixed with 4% paraformaldehyde (15 min 
at room temperature). After incubation with 
the primary antibody (1:500) overnight at 
4°C, p-LKB1(Ser428) in N2a cells was located 
using an antibody conjugated to Alexa-488. 
Nuclei were labeled with 4,6-diamindino-2-
-phenylindole (DAPI; 1 µg/mL in PBS). 
Images of fluorescence were acquired using the 
Leica TCS SP confocal laser-scanning micro-
scope (Leica, Heidelberg, Germany).
Cell transfection. N2a cells were cultured 
for 2 days before transfections. According to 
the manufacturer’s protocol, cells were trans-
fected with either CA-AMPK or DN-AMPK 
plasmid using a Nucleofector instrument 
(Amaxa) and Nucleofector Kit V optimized 
for use with N2a cells. Briefly, 2 × 106 cells 
were resuspended in 100 µL transfection buf-
fer, and DNA plasmid was added to cells that 
were transferred to the cuvettes and electro-
porated using program T-24 (Amaxa).
ROS measurement. We detected ROS using 
the fluores  cent dye dichloro  dihydro  fluorescein 
acetate (DCFDA) and the hydro  ethidine (HE) 
staining method (Liao et al. 2000). HE is 
selectively oxidized by the superoxide anion 
(O2·
–) into fluorescent ethidium, and DCFDA 
labels oxidation by hydrogen peroxide (H2O2), 
peroxy  nitrite, or the hydroxyl radical into flu-
orescent dichloro  dihydro  fluorescein (DCF). 
After treatment with RA in the presence or 
absence of As, N2a cells were collected, washed, 
incubated with 10 µM DCFDA or 5 µM 
HE for 30 min at 37°C, and then analyzed 
with a FACSCalibur flow cytometer (Becton 
Dickinson, Franklin Lakes, NJ, USA).
Statistical analysis. Differences among 
treatment groups were tested using analysis of 
variance. We consider a p-value of < 0.05 sta-
tistically significant. In cases where significant 
differences were detected, we performed spe-
cific post hoc comparisons between treatment 
groups using Student-Newman-Keuls tests. The 
analyses were performed using SPSS software 
(version 10.0; SPSS Inc., Chicago, IL, USA).
Results
Arsenic inhibits neurite outgrowth. To deter-
mine the effect of As exposure on neuronal dif-
ferentiation, we treated differentiating N2a cells 
with various concentrations of As (0–10 µM) for 
0–48 hr. As shown in Figure 1A, RA treatment 
resulted in visible changes in cell morphology, 
such as shrinkage of the cell body and neurite 
outgrowth (appearance of processes longer than 
the cell body). Combined RA/As treatment 
exerted an inhibitory effect on neurite outgrowth 
in a dose-dependent (Figure 1A) and time-
dependent (Figure 1B) manner. We observed 
a noticeable reduction in both the number of 
cells bearing neurites and neurite length, com-
pared with RA treatment alone (Figure 1A,B). 
The number of neurite-bearing cells and the 
length of neurites were reduced by 55% and 
69%, respectively, after exposure to 3 µM As for 
48 hr (Figure 1C). To determine whether this 
effect was a consequence of general toxicity due 
to As, we meas  ured cell viability by the MTT 
assay. Arsenic concentrations of 0.5–5 µM 
had no effect on the cell viability, whereas 
10 µM As caused 35% cell death after 48 hr 
exposure [see Supplemental Material, Figure 1 
(doi:10.1289/ehp.0901510)]. Based on these 
results, we selected 3 µM As for all of our fol-
lowing studies. NFs and microtubule-associated 
protein-2 (MAP2) are critical for neurite out-
growth and dendrite development. Consistent 
with morphological differentiation, NFs and 
MAP2 were down-regulated by As exposure. 
Immunocytochemistry with antibody against 
the neuron-specific protein MAP2 revealed 
reduced neurite outgrowth in cells exposed to 
As (See Supplemental Material, Figure 2). These 
data suggest that As at low exposure levels inhib-
ited neurite outgrowth in N2a cells.
Arsenic inhibits activation of AMPK. 
AMPK activation requires phosphorylation of 
Thr172 in the activation loop of its cata  lytic 
α subunits [AMPK(Thr172)]. We sought to 
determine whether As affected the activation of 
AMPK in differentiating N2a cells. As shown 
in Figure 2, RA treatment resulted in a robust 
Figure 2. Arsenic inhibits AMPK activation in N2a 
cells treated with RA or RA plus 3 µM As for 6–48 hr. 
The expression of AMPK, ACC, p-AMPK, and p-ACC 
was determined with immuno  blotting. GADPH was 
used as the loading control in the immunoblot. 
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increase in phosphorylated AMPK(Thr172) 
[p-AMPKα(Thr172)] within 6 hr that per-
sisted for up to 48 hr. Exposure to 3 µM As for 
24 hr resulted in rapid and continuous reduc-
tion in AMPKα phosphorylation, decreasing 
by 90% compared with RA treatment. This 
was also accompanied by a rapid and sustained 
decrease in phosphorylation of the AMPK 
β subunit (AMPKβ), a positive regulator of 
AMPK activity [see Supplemental Material, 
Figure 3 (doi:10.1289/ehp.0901510)]. To 
confirm the effect of As on AMPK activation, 
we monitored phosphorylation of acetyl-coen-
zyme A carboxylase (ACC), a primary target 
of activated AMPK. The profile of As-induced 
decrease of phosphorylated ACC (p-ACC) was 
similar to that of p-AMPKα(Thr172). Total 
AMPK and ACC levels changed minimally 
at all the time points in both RA- and RA/
As-treated groups.
Arsenic inhibits neurite outgrowth by 
blocking AMPK activation. To verify the role 
of AMPK in As-induced inhibition on neurite 
outgrowth, we used an AMPK pharmacologi-
cal activator or genetic manipulation with a 
CA-AMPK plasmid. Pretreatment with 4 mM 
5-aminoimidazole-4-carboxamide riboside 
Figure 3. AMPK inactivation causes As-induced inhibition of neurite outgrowth. (A) Effect of pretreatment with 4 mM AICAR or 20 µM CC (or transfection with 
CA-AMPK or DN-AMPK on neurite outgrowth in differentiating N2a cells exposed to RA or RA plus 3 µM As for 48 hr. Blots show the efficiency of CC, ACAR, 
DN-AMPK, and CA-AMPK on the activation of AMPK using the expression of p-ACC and c-myc. Images represent typical fields of cells viewed with an inverted 
light microscope; bars = 100 µm. (B) Percentage of cells exhibiting neurites (left) and average neurite length (right) in 200 cells. Each data point is the mean ± SE 
of three independent experiments.
*p < 0.05 compared with RA treatment alone. #p < 0.05 compared with RA plus As-treatment. 
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(AICAR) or transfection with CA-AMPK 
protected differentiating N2a cells against 
inhibition of neurite outgrowth induced by 
As (Figure 3A), by increasing the percent-
age of cells bearing neurites and restoring the 
average neurite length to values comparable 
with those from RA treatment (Figure 3B). 
Even after reestablishing AMPK activity, 
neurite outgrowth continued to be lower in 
the As-treated cells than in those treated only 
with RA (Figure 3B). Other targets of LKB1 
could be acting in parallel, which could be 
less sensitive to As. Pretreatment with 20 µM 
compound C (CC), an AMPK inhibitor, or 
expression of DN-AMPK in RA treatment 
culture had an inhibitory effect on neurite 
outgrowth similar to that of As (Figure 3A,B), 
indicating the important role of AMPK dur-
ing neurite differentiation. Taken together, 
these results indicate that AMPK inactivation 
plays an important role in As-induced inhibi-
tion of neurite outgrowth.
Arsenic inhibits activation of LKB1. To 
evaluate the upstream kinase affected by As in 
blunted AMPK activation, we examined the 
effect of As on the activation of LKB1, a major 
AMPK-kinase, in N2a cells. Phosphorylation 
of LKB1(Ser428) induced by RA was 
decreased by 56% after 12 hr of exposure to 
As and remained at a very low level until 48 hr 
[Figure 4A; see also Supplemental Material, 
Figure 4 (doi:10.1289/ehp.0901510)]. Overall 
LKB1 expression was not changed by As expo-
sure. However, the distribution and expres-
sion of p-LKB1(Ser428) in the cytoplasm 
differed between RA and combined RA/As   
treatment (Figure 4B; see Supplemental 
Material, Figure 5). RA treatment increased 
the level of p-LKB1(Ser428) during the early 
stage of differentiation, which remained at 
high levels until 36 hr, whereas As exposure 
inhibited the increase. In the nuclear fraction, 
the RA-induced decrease in p-LKB1(Ser428) 
was blocked by As. In the absence of As, 
the profile of expression of LKB1 in cyto-
plasm and nucleus was similar with that of 
p-LKB1(Ser428) in cytoplasm and nucleus, 
respectively. Because overall LKB1 expression 
was not changed by As, this profile suggested 
that As blocked the RA-induced translocation 
of LKB1 from nucleus to cytoplasm in differ-
entiating N2a cells. 
We further examined the subcellular dis-
tribution of p-LKB1(Ser428) in N2a cells with 
immuno  fluorescence staining. Consistent with 
the observation obtained from immuno  blotting 
analysis, As failed to stimulate and induce 
cytoplasm trans  location of p-LKB1(Ser428) 
(Figure 4C). To confirm the inactivation of 
LKB1, we examined the effect of As on LKB1/
STRAD/MO25 interaction in N2a cells with 
a coimmuno  precipitation assay. RA treatment 
increased the association of LKB1, MO25, and 
STRAD during the period of neurite outgrowth 
(Figure 4D); combined RA/As treatment 
decreased that association but did not affect 
their expression. Taken together, these results 
indicate that LKB1 inactivation plays a role in 
inhibition of AMPK activation by As.
ROS suppress the LKB1–AMPK pathway. 
Arsenic is a well-known ROS inducer, and 
generation of ROS associated with As expo-
sure has been shown to play a fundamental 
role in the induction of adverse health effects 
(Shi et al. 2004). The role of ROS in reduced 
neurite outgrowth has been explained by the 
observation that ROS induces reconfigura-
tion of micro  tubules (He et al. 2002; Ibi et al. 
2006). We therefore sought to determine 
whether oxidative stress was involved in the 
reduced neurite outgrowth induced by As. 
The fluorescence intensity produced by both 
DCFDA and HE was significantly higher in 
differentiating cells than in untreated control 
Figure 4. Arsenic inhibits LKB1 activation. N2a cells were treated with RA or RA plus 3 µM As. Immunoblots 
showing expression of LKB1 and p-LKB1(Ser428) (A) and effect of As on p-LKB1(Ser428) distribution (B) in N2a 
cells at five time points; GADPH and lamin A/C served as loading controls of cytoplasm and nucleus, respec-
tively. (C) Effect of As on localization of p-LKB1(Ser428) in N2a cells treated for 24 hr. Immuno  fluorescence indi-
cates expression of p-LKB1(Ser428) as green, and nuclei (blue) were visualized with DAPI staining. (D) Effect 
of As on LKB1/MO25/STRAD interaction in treated N2a cells at four time points. IP, immunoprecipitated.
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cells (Figure 5A). Combined RA/As treatment 
stimulated greater formation of ROS com-
pared with RA treatment. We observed the 
higher fluorescence levels from 6 hr in both 
RA and combined RA/As treatment (data 
not shown), and these higher levels persisted 
for up to 48 hr. The intensity of HE reached 
a maximum increase at 24 hr with both RA 
and combined RA/As treatment, whereas 
the intensity of DCF peaked at 48 hr. These 
results indicate that more ROS was produced 
by As during neurite outgrowth.
To verify the role of ROS in reduced neu-
rite outgrowth induced by As, we examined 
the effects of the anti  oxidants NAC (a potent 
anti  oxidant), SOD (an O2·
– scavenger), and 
catalase (an H2O2 scavenger) (Figure 5B,C). 
When 2 mM NAC or 500 U/mL SOD was 
included in the medium with RA plus As for 
48 hr, we observed that the inhibitory effect 
of As on neurite outgrowth was significantly 
reversed, as shown by increased percentages 
of cells bearing neurites and greater neurite 
elongation (Figure 5C). NAC completely 
reversed the reduction in neurite outgrowth 
induced by As. In contrast, inclusion of 
500 U/mL catalase did not affect neurite out-
growth (Figure 5C). We observed no signifi-
cant change in cell viability in the presence of 
these reagents (data not shown). Accordingly 
ROS, especially O2·
–, but not H2O2, appears 
to be involved in the reduced neurite out-
growth induced by As. To identify the effect 
of ROS on the LKB1–AMPK pathway, 
we examined the effects of the anti  oxidants 
NAC, SOD, and catalase on phosphoryla-
tion levels of AMPK and LKB1. As shown 
in Figure 5D, pre  treatment with NAC or 
SOD, but not catalase, protected against the 
As-induced decrease in p-AMPK(Thr172) and 
p-LKB1(Ser428) and had no effect on protein 
expression. We further examined the effect of 
ROS on the association of LKB1, MO25, and 
STRAD and found that the disrupted associa-
tion of LKB1, MO25, and STRAD induced 
by As was reversed by pretreatment with NAC 
or SOD but not catalase (Figure 5E). Taken 
together, these results verify that ROS, espe-
cially O2·
–, plays a critical role in reduced 
neurite outgrowth induced by As through the 
LKB1–AMPK pathway.
Discussion
In the present study we found that As inhibits 
neurite outgrowth in N2a cells, and this inhi-
bition is due to deficient activation of AMPK 
as a consequence of decreased activation of 
LKB1. Arsenic suppresses LKB1 activity and 
the trans  location from nucleus to cytoplasm 
by disrupting the association of the LKB1/
MO25/STRAD complex and inhibiting 
the phosphorylation of LKB1(Ser428). The 
antioxidants NAC and SOD antagonize the 
inhibitory effect of As by reversing decreased 
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Figure 5. The role of ROS on the reduced neurite out-
growth in N2a cells exposed to RA or RA plus 3 µM As. 
Abbreviations: +, with; –, without; IP, immunoprecipi-
tated. (A) ROS production evaluated by intensity of DCF 
and HE fluorescence (fold increase of control); each 
data point represents the mean ± SE of three indepen-
dent experiments. (B,C) Effect of the antioxidants NAC, 
SOD, and catalase (CAT) on reduced neurite outgrowth 
induced by As. (B) Images of typical fields of cells 
viewed with an inverted light microscope; bar = 100 µm. 
(C) Percentage of cells exhibiting neurites (left) and 
average neurite length (right) in 200 cells; each data 
point represents the mean ± SE of three independent 
experiments. (D) Effect of antioxidants on the expression 
of p-AMPKα(Thr172) and p-LKB1(Ser428) in differentiat-
ing cells exposed to As for 24 hr; GADPH served as the 
loading control. (E) Effect of antioxidants on association 
of LKB1/MO25/STRAD in differentiating cells exposed to 
As for 24 hr.
*p < 0.05 compared with control. #p < 0.05 compared with RA 
treatment. ##p < 0.05 compared with RA plus As treatment.Inhibition of LKB1–AMPK pathway by arsenic
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p-AMPK(Thr172) and p-LKB1(Ser428) levels 
and restoring disrupted LKB1/MO25/STRAD 
association. The results suggest that ROS plays 
an important role in neuronal differentiation 
and mediating the action of As.
Arsenic at low concentrations (≤ 5 µM) 
inhibits neurite outgrowth, as demonstrated 
by decreased percentages of cells bearing neu-
rites and decreased neurite length, which is 
consistent with other As studies (DeFuria 
and Shea 2007; Frankel et al. 2009). Arsenic, 
at concentrations of 5 and 10 µM, disrupts 
neurite growth and complexity in differentiat-
ing PC12 pheochromocytoma cells (Frankel 
et al. 2009). Arsenic concentrations < 1 µM 
inhibit NF transport into axons in NB2/d1 
cells and cultured dorsal root ganglion neurons 
(DeFuria and Shea 2007). However, some 
studies have reported that low As concentra-
tions (0.5–1 µM) stimulate neurite outgrowth 
(Jung et al. 2006). One explanation for the 
observed differences in results is the differing 
cell culture conditions used during the differ-
entiation treatments, most notably the presence 
or absence of serum. However, this is not likely 
to be the only contributing factor.
Arsenic-induced inhibition of neurite 
outgrowth is mediated by its modulation of 
AMPK activity, which is crucial for main-
taining the structural and functional integrity 
of neurons, as demonstrated by the loss of 
axonal and dendritic processes in β- (Spasić 
et al. 2008) or γ- (Tschäpe et al. 2002) sub-
unit–deficient Drosophila models, and for 
contributing to robust neurite outgrowth in 
N2a cells induced by resveratrol (Dasgupta 
and Milbrandt 2007). Compared with the RA 
treatment, combined RA/As treatment inhib-
ited phosphorylation of AMPKα(Thr172), as 
well as phosphorylation of ACC, a substrate 
of AMPK. The phosphorylation of AMPKβ, 
which mediates the association of the AMPK 
hetero  trimeric complex, also decreased in a 
time-dependent manner. Pretreatment with 
the AMPK pharmacological activator AICAR 
or transfection with a CA-AMPK plasmid led 
to a recovery effect on reduced neurite out-
growth induced by As, suggesting that blunted 
AMPK activation is responsible for the inhibi-
tory effect of As.
The loss of AMPK activity induced by 
As is due to the suppression of LKB1 activ-
ity and translocation, by disturbing the asso-
ciation of the LKB1/MO25/STRAD complex, 
as well as inhibiting the phosphorylation of 
LKB1(Ser428). AMPK activity is regulated 
through phosphorylation at Thr172 by the 
upstream serine/threonine kinase LKB1, the 
localization of which depends on its kinase 
activity. LKB1 forms a hetero  trimeric com-
plex with STRAD and MO25, which are 
required for its activation and cytosolic local-
ization. In the absence of these proteins, LKB1 
is localized to the nucleus. Formation of the   
LKB1/MO25/STRAD complex causes a relo-
calization of LKB1 to the cytosol and enhances 
LKB1 activity (Boudeau et al. 2003; Shaw 
et al. 2004). Phosphorylation of LKB1(Ser428) 
is reported to result in translocation of LKB1 
and increase association of LKB1 with AMPK 
(Xie et al. 2006). In addition, interaction of 
STRAD with LKB1 promotes phosphoryla-
tion of LKB1 (Shelly et al. 2007). The present 
study demonstrates that As time-dependently 
decreases p-LKB1(Ser428) and disrupts LKB1/
STRAD/MO25 association, which blocks 
cytoplasm translocation of LKB1. The inhibi-
tory effect of As on LKB1 trans  location from 
nucleus to cytoplasm suggests that LKB1 
inactivation is involved in deficient activ-
ity of AMPK induced by As. Besides LKB1 
activation, AMPK can also be activated by 
CaMKKβ, which is stimulated by intra  cellular 
calcium (Carling et al. 2008). Several recent 
studies have reported that As increases the 
intra  cellular calcium overload, and the increase 
is not reversible if As is removed (e.g., Günes 
et al. 2009). In the present study we found 
no obvious difference in the expression of 
CaMKKβ between RA and treatment with RA 
plus As [see Supplemental Material, Figure 6 
(doi:10.1289/ehp.0901510)]. Thus, the loss of 
AMPK activity induced by As is likely caused 
by LKB1 inactivation.
The present study also shows that oxida-
tive stress induced by As, especially O2·
–, plays 
a critical role in blocking the LKB1–AMPK 
pathway. Modulation of ROS levels influences 
multiple aspects of neuronal differentiation and 
function (Tsatmail et al. 2006). Physiological 
levels of ROS are critical for maintaining a 
dynamic F-actin cyto  skeleton and controlling 
neurite outgrowth (Munnamalai and Suter 
2009). However, excessive ROS plays a neuro-
toxic role during differentiation that likely con-
tributes to brain dysfunction (Lee et al. 2002; 
Tsatmail et al. 2006). In our study, the anti-
oxidants NAC and SOD protected against 
reduced neurite outgrowth induced by As by 
recovering As-disrupted LKB1/MO25/STRAD 
association and the level of p-LKB1(Ser428). 
The function of SOD is to catalyze the dismu-
tation reaction of O2·
– to generate H2O2. Our 
results indicate that H2O2 may not play an 
important develop  mental neuro  toxic role in the 
As model, because its formation should have 
been greatly increased by the supplemented 
SOD. Instead, an increase in the steady-state 
levels of O2·
– appears to be pivotal to inhib-
iting neurite outgrowth. An important issue 
for understanding the physiological level of 
ROS in neuronal differentiation concerns the 
intriguing role of ROS during differentiation. 
High ROS levels have been reported to be 
transient in vivo during neuronal development, 
suggesting that some feedback loop must exist 
to decrease the levels of ROS during neuron 
differentiation (Tsatmail et al. 2006). Mutation 
in the human copper/zinc SOD gene results in 
defects in neurite outgrowth, leading to the 
decrease in the amount of NFs and MAP2 (Lee 
et al. 2002). Resveratrol promotes develop  ment 
by significantly increasing manganese SOD 
expression and intra  cellular glutathione level 
(Kao et al. 2010). Taken together, excess ROS 
induced by As may play a critical role in inhib-
iting neurite outgrowth and the LKB1–AMPK 
pathway.
Conclusion
Results of the present study demonstrate that 
reduced neurite outgrowth induced by As 
results from inhibition of AMPK activity as 
a consequence of LKB1 inactivation. Arsenic 
suppresses LKB1 activity and translocation 
from nucleus to cytoplasm by disrupting the 
association of the LKB1/MO25/STRAD 
complex, as well as inhibiting the phospho-
rylation of LKB1(Ser428). ROS induced by 
As, especially excessive O2·
–, plays a critical 
role in blocking the LKB1–AMPK pathway. 
Our studies provide insight into the under-
lying mechanisms of As-induced damage to 
the developing CNS and provide important 
information for therapeutic approaches.
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